"Hořovická nemocnice poskytuje specializované zdravotní služby nad rámec základních medicínských oborů, zejména na svém ortopedickém a neurologickém oddělení, na odděleních anestesiologie a resuscitace, vnitřního lékařství, chirurgie, gynekologie a porodnictví a v neposlední řadě na oddělení pro děti. Za posledních deset let prošla nemocnice rozsáhlou přestavbou, nejdříve ve své ambulantní a posléze i lůžkové části. V současnosti jsou všechna její lůžková oddělení vybavena jedno až čtyřlůžkovými pokoji s vlastním hygienickým zařízením, televizí a přístupem k internetu."

During the past decade, Nemocnice Horovice conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Horovice" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Egetis Therapeutics" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Horovice" #1 collaborator was "Solasia Pharma K.K." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Horovice" are "Crohn's Disease" (6 trials), "Colorectal Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Chemotherapy-induced Peripheral Neuropathy" (2 trials) and "Complex Perianal Fistula" (2 trials). Many other conditions were trialed in "Nemocnice Horovice" in a lesser frequency.

Most popular intervention types in "Nemocnice Horovice" are "Drug" (14 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (3 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "Darvadstrocel" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Horovice" are 16 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nemocnice Horovice". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nemocnice Horovice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Horovice, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".